Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.26 USD | +0.71% | +3.65% | +17.03% |
Apr. 29 | MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment | MT |
Apr. 29 | MannKind Gets FDA Clearance for Clofazimine IND Application | DJ |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 4.550 | 5.270 | 5.270 |
Spread/Res. | -6.37% | -19.17% | -19.17% |
Spread/Supp. | +5.19% | +31.08% | +29.88% |
Support | 4.050 | 3.250 | 3.280 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MNKD Stock
- Charts MannKind Corporation